Ex-OpenAI science head Kevin Weil launches Warp Sciences with $215M
Kevin Weil, who led OpenAI's science efforts, has launched Warp Sciences, an automated drug-development lab, with a $215M round led by Lightspeed. The deal values the company at $865M. Warp Sciences aims to bring a pharma step long outsourced to Chinese firms such as WuXi AppTec back to the US.